Healthcare
HTGF backs Amal Therapeutics' CHF 3m series-A
Round also saw participation from Boehringer Ingelheim Venture Fund and VI Partners
Deal in Focus: Adelis in DKK 250m buyout of SSI Diagnostica
Swedish GP Adelis completes the DKK 250m privatisation of Danish niche pharma company SSI Diagnostica
Baxalta and Medicxi lead €7m series-A for Gadeta
Backers include Utrecht Holdings, founders and the management team
Iterum Therapeutics raises $40m
Newly created company has also been granted global licensing rights for a new antibiotic
Riverside sells Diatron to Stratec Biomedical
Trade sale brings to an end Riverside's 11 years of ownership of the Budapest-based company
BDC acquires Acteon
Bridgepoint Development Capital II has made its second acquisition since launch
Spring Ventures backs £10m HFH MBO
Spring Ventures also underwrote the debt for the deal
Mid Europa's Regina Maria bolts on hospital
Ponderas Hospital is the first add-on acquisition for the Romanian healthcare group since the Mid Europa buyout
Endeavour Medtech Growth closes on €250m
Endeavour Vision's decision to focus purely on medtech investments helped it secure new investors
Epidarex leads €14m series-A for Topas Therapeutics
Backers include life-sciences-focused investors Gimv, EMBL Ventures and Evotec
Atlantic Healthcare raises $24m from LDC et al.
Funding will allow the company to complete phase-3 trials of its inflammatory bowel disease treatment
Sofinnova leads €22.5m Gecko Biomedical round
Extension to series-A round also includes BPI France, Omnes, CM-CIC Innovation and CapDecisif
Ardian sells KOS to CIR and F2i for €292m
CIR has raised its stake in the business to 62.7%, while F2i has taken a 37.7% stake
Cambridge Epigenetix raises $21m series-B
The company raised funds from GV, Sequoia Capital, New Science Ventures and others
Caixa leads €2.2m series-B for Inbiomotion
Existing investors Ysios Capital and Fundación Vila Casas also participated in the round
Deal in Focus: Trilantic's investment in Maugeri highlights structural healthcare reform
An in-depth look at Trilantic’s third investment in the Italian healthcare sector
CVC acquires Doc Generici from Charterhouse
Charterhouse's ninth fund scores a 2.7x money multiple with a 40% IRR following the sale
Panakès launches first Italian medtech early-stage vehicle
Maiden medtech venture capital fund targets a €100m final close by the end of the year
Sovereign's Outcomes First buys Options Group
Newly-combined company will provide care for 700 children and young adults
HealthCap, Versant et al. lead SEK 437m series-B for Aprea
Round is among the largest venture investments in Nordic healthcare ever, according to unquoteт data
Advent and Medicxi lead £11m series-A for Capella
Round for London-based biotech firm saw participation from two VCs and Osage University Partners
Altitude scores 2.9x on The Care Division exit
Deal marks the fourth bolt-on acquisition for Bridges Ventures-backed Alina
Azulis leads Destia MBO
BNP Paribas Développement, Societe Generale Capital Partenaires and management co-invested
Duke Street leads MBO for Medi-Globe Corporation
DB Private Equity, Atnahs Capital, Brederode and Harwood also joined the buyout